Germany · Delayed Price · Currency is EUR Hofseth BioCare ASA Statistics
Total Valuation
FRA:HBQ has a market cap or net worth of EUR 64.41 million. The enterprise value is 82.59 million.
| Market Cap | 64.41M |
| Enterprise Value | 82.59M |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 498.89M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 25.65% |
| Owned by Institutions (%) | 33.73% |
| Float | 253.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.03 |
| PB Ratio | -27.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.43 |
| EV / Sales | 3.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -30.85 |
Financial Position
The company has a current ratio of 0.81
| Current Ratio | 0.81 |
| Quick Ratio | 0.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.93 |
| Interest Coverage | -5.41 |
Financial Efficiency
Return on equity (ROE) is -346.49% and return on invested capital (ROIC) is -25.33%.
| Return on Equity (ROE) | -346.49% |
| Return on Assets (ROA) | -18.45% |
| Return on Invested Capital (ROIC) | -25.33% |
| Return on Capital Employed (ROCE) | -64.14% |
| Revenue Per Employee | 283,388 |
| Profits Per Employee | -148,276 |
| Employee Count | 78 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 2.54 |
Taxes
In the past 12 months, FRA:HBQ has paid 15,018 in taxes.
| Income Tax | 15,018 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.28% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.28% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 41.91 |
| Average Volume (20 Days) | 375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:HBQ had revenue of EUR 21.25 million and -11.12 million in losses. Loss per share was -0.03.
| Revenue | 21.25M |
| Gross Profit | 6.37M |
| Operating Income | -9.53M |
| Pretax Income | -11.11M |
| Net Income | -11.12M |
| EBITDA | -8.35M |
| EBIT | -9.53M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 5.59 million in cash and 23.91 million in debt, giving a net cash position of -18.32 million.
| Cash & Cash Equivalents | 5.59M |
| Total Debt | 23.91M |
| Net Cash | -18.32M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.38M |
| Book Value Per Share | -0.01 |
| Working Capital | -3.49M |
Cash Flow
In the last 12 months, operating cash flow was -1.82 million and capital expenditures -852,043, giving a free cash flow of -2.68 million.
| Operating Cash Flow | -1.82M |
| Capital Expenditures | -852,043 |
| Free Cash Flow | -2.68M |
| FCF Per Share | n/a |
Margins
Gross margin is 29.99%, with operating and profit margins of -44.83% and -52.32%.
| Gross Margin | 29.99% |
| Operating Margin | -44.83% |
| Pretax Margin | -52.25% |
| Profit Margin | -52.32% |
| EBITDA Margin | -39.29% |
| EBIT Margin | -44.83% |
| FCF Margin | n/a |
Dividends & Yields
FRA:HBQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.03% |
| Shareholder Yield | -1.03% |
| Earnings Yield | -17.26% |
| FCF Yield | -4.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |